Academic Journal
Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
| Τίτλος: | Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes. |
|---|---|
| Συγγραφείς: | Apaolaza PS; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany., Chen YC; Department of Surgery, University of British Columbia & BC Children's Hospital Research Institute, Vancouver, BC, Canada., Grewal K; Department of Surgery, University of British Columbia & BC Children's Hospital Research Institute, Vancouver, BC, Canada., Lurz Y; Technical University of Munich, Munich, Germany., Boulassel S; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany., Verchere CB; Department of Surgery, University of British Columbia & BC Children's Hospital Research Institute, Vancouver, BC, Canada. bverchere@bcchr.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia & BC Children's Hospital Research Institute, Vancouver, BC, Canada. bverchere@bcchr.ca.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. bverchere@bcchr.ca., Rodriguez-Calvo T; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany. teresa.rodriguez@helmholtz-munich.de. |
| Πηγή: | Diabetologia [Diabetologia] 2024 Dec; Vol. 67 (12), pp. 2771-2785. Date of Electronic Publication: 2024 Oct 15. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Berlin Springer Verlag |
| Ιατρικοί όροι (MeSH): | Proprotein Convertase 1*/metabolism , Proprotein Convertase 1*/genetics , Diabetes Mellitus, Type 1*/metabolism , Diabetes Mellitus, Type 1*/pathology , Islets of Langerhans*/metabolism , Islets of Langerhans*/pathology, Glucagon-Secreting Cells/metabolism ; Glucagon-Secreting Cells/pathology ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Insulin-Secreting Cells/metabolism ; Insulin-Secreting Cells/pathology ; Pancreas/metabolism ; Pancreas/pathology ; Humans ; Male ; Female ; Adult ; Tissue Donors ; Middle Aged ; Cross-Sectional Studies ; Young Adult |
| Περίληψη: | Aims/hypothesis: Islet prohormone-processing enzymes convert peptide hormone precursors to mature hormones. Defective beta cell prohormone processing and the release of incompletely processed peptide hormones are observed prior to the onset of diabetes, yet molecular mechanisms underlying impaired prohormone processing during the development of diabetes remains largely unknown. Previous studies have shown that prohormone convertase 1/3 (PC1/3) protein and mRNA expression levels are reduced in whole islets from donors with type 1 diabetes, although whether PC1/3-mediated prohormone processing in alpha and beta cells is disrupted in type 1 diabetes remained to be explored. Herein, we aimed to analyse the expression of PC1/3 in islets from non-diabetic donors, autoantibody-positive donors and donors diagnosed with type 1 diabetes or type 2 diabetes. Methods: Immunostaining and high-dimensional image analysis were performed on pancreatic sections from a cross-sectional cohort of 54 donors obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD) repository, to evaluate PC1/3 expression patterns in islet alpha, beta and delta cells at different stages of diabetes. Results: Alpha and beta cell morphology were altered in donors with type 1 diabetes, including decreased alpha and beta cell size. As expected, the insulin-positive and PC1/3-positive areas in the islets were both reduced, and this was accompanied by a reduced percentage of PC1/3-positive and insulin-positive/PC1/3-positive cells in islets. PC1/3 and insulin co-localisation was also reduced. The glucagon-positive area, as well as the percentage of glucagon-positive and glucagon-positive/PC1/3-positive cells in islets, was increased. PC1/3 and glucagon co-localisation was also increased in donors with type 1 diabetes. The somatostatin-positive cell area and somatostatin staining intensity were elevated in islets from donors with recent-onset type 1 diabetes. Conclusions/interpretation: Our high-resolution histomorphological analysis of human pancreatic islets from donors with and without diabetes has uncovered details of the cellular origin of islet prohormone peptide processing defects. Reduced beta cell PC1/3 and increased alpha cell PC1/3 in islets from donors with type 1 diabetes pinpointed the functional deterioration of beta cells and the concomitant potential increase in PC1/3 usage for prohormone processing in alpha cells during the pathogenesis of type 1 diabetes. Our finding of PC1/3 loss in beta cells may inform the discovery of new prohormone biomarkers as indicators of beta cell dysfunction, and the finding of elevated PC1/3 expression in alpha cells may encourage the design of therapeutic targets via leveraging alpha cell adaptation in diabetes. (© 2024. The Author(s).) |
| Competing Interests: | Acknowledgements: We thank the organ donors and their families. We thank the Network for Pancreatic Organ Donors (nPOD) and especially thank I. Kusmartseva and M. Yang (Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, USA) for pancreatic tissue sample procurement and distribution. We also thank P.-I. Petropoulou (Institute of Diabetes Research, Helmholtz Zentrum München, Germany) for helpful suggestions to the project. We acknowledge technical support from the Imaging Core at the Canucks for Kids Childhood Diabetes Laboratory at BC Children’s Hospital Research Institute. Data availability: Raw data and images are available upon request. Funding: Open Access funding enabled and organized by Projekt DEAL. This work was supported by grants from Breakthrough T1D (3-COE-2022-1103-M-B) through Breakthrough T1D Centre of Excellence at University of British Columbia and Canadian Institutes of Health and Research (CIHR PJT-153156) to CBV, a Breakthrough T1D Advanced Postdoctoral Fellowship (3-APF-2022–1141-A-N) to Y-CC, a University of British Columbia Faculty of Medicine Summer Studentship (to KG), and a career development award from Breakthrough T1D (5-CDA-2020–949-A-N) to TR-C. Research in the Rodriguez-Calvo laboratory is supported by IMI2-JU under grant agreement no. 115797 (INNODIA) and no. 945268 (INNODIA HARVEST). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation programme and EFPIA, Breakthrough T1D and The Leona M. and Harry B. Helmsley Charitable Trust. The study sponsor/funder was not involved in the design of the study; the collection, analysis and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report. Authors’ relationships and activities: The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work. Contribution statement: PSA contributed to study design, data analysis, interpretation of data and drafted the manuscript. Y-CC contributed to the study conception and design, acquisition, analysis and interpretation of data and drafted the manuscript. YL and SB contributed to data analysis, and reviewed the manuscript. KG contributed to data acquisition and reviewed the manuscript. CBV contributed to the conception and design, interpretation of data and reviewed the manuscript. TR-C contributed to interpretation of data, and edited and reviewed the manuscript. PSA and Y-CC contributed equally to this work. All authors have approved the final version of the manuscript to be published. Both CBV and TR-C are guarantors of this study. |
| References: | Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A (2021) Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nat Rev Endocrinol 17(3):150–161. https://doi.org/10.1038/s41574-020-00443-4. (PMID: 10.1038/s41574-020-00443-433293704) Atkinson MA, Mirmira RG (2023) The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas. Cell Metab 35(9):1500–1518. https://doi.org/10.1016/j.cmet.2023.06.018. (PMID: 10.1016/j.cmet.2023.06.0183747884210529265) Campbell-Thompson M, Fu A, Kaddis JS et al (2016) Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes 65(3):719–731. https://doi.org/10.2337/db15-0779. (PMID: 10.2337/db15-077926581594) Sims EK, Mirmira RG, Evans-Molina C (2020) The role of beta-cell dysfunction in early type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 27(4):215–224. https://doi.org/10.1097/MED.0000000000000548. (PMID: 10.1097/MED.0000000000000548326186337365587) Van Dalem A, Demeester S, Balti EV et al (2016) Prediction of impending type 1 diabetes through automated dual-label measurement of proinsulin:C-peptide ratio. PLoS One 11(12):e0166702. https://doi.org/10.1371/journal.pone.0166702. (PMID: 10.1371/journal.pone.0166702279070065131964) Truyen I, Pauw PD, Jørgensen PN et al (2005) Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 48(11):2322–2329. https://doi.org/10.1007/s00125-005-1959-0. (PMID: 10.1007/s00125-005-1959-016211374) Sims EK, Chaudhry Z, Watkins R et al (2016) Elevations in the fasting serum proinsulin-to-C-peptide ratio precede the onset of type 1 diabetes. Diabetes Care 39(9):1519–1526. https://doi.org/10.2337/dc15-2849. (PMID: 10.2337/dc15-2849273853275001142) Kahn SE, Chen Y-C, Esser N et al (2021) The β cell in diabetes: integrating biomarkers with functional measures. Endocr Rev 42(5):528–583. https://doi.org/10.1210/endrev/bnab021. (PMID: 10.1210/endrev/bnab021341809799115372) Wasserfall C, Nick HS, Campbell-Thompson M et al (2017) Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab 26(3):568-575.e3. https://doi.org/10.1016/j.cmet.2017.08.013. (PMID: 10.1016/j.cmet.2017.08.013288774605679224) Sims EK, Syed F, Nyalwidhe J et al (2019) Abnormalities in proinsulin processing in islets from individuals with longstanding T1D. Transl Res 213:90–99. https://doi.org/10.1016/j.trsl.2019.08.001. (PMID: 10.1016/j.trsl.2019.08.001314424186783367) Teitelman G (2022) Abnormal expression of an insulin synthesizing enzyme in islets of adult autoantibody positive donors. J Histochem Cytochem 70(10):695–706. https://doi.org/10.1369/00221554221138368. (PMID: 10.1369/00221554221138368363415519660365) Rodriguez-Calvo T, Chen Y-C, Verchere CB et al (2021) Altered β-cell prohormone processing and secretion in type 1 diabetes. Diabetes 70(5):1038–1050. https://doi.org/10.2337/dbi20-0034. (PMID: 10.2337/dbi20-0034339477218173804) Kilimnik G, Kim A, Steiner DF, Friedman TC, Hara M (2010) Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration. Islets 2(3):149–155. https://doi.org/10.4161/isl.2.3.11396. (PMID: 10.4161/isl.2.3.1139620657753) Saikia M, Holter MM, Donahue LR et al (2021) GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells. JCI Insight 6(3):e141851. https://doi.org/10.1172/jci.insight.141851. (PMID: 10.1172/jci.insight.141851335549587934853) Wideman RD, Covey SD, Webb GC, Drucker DJ, Kieffer TJ (2007) A switch from Prohormone Convertase (PC)-2 to PC1/3 expression in transplanted α-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice. Diabetes 56(11):2744–2752. https://doi.org/10.2337/db07-0563. (PMID: 10.2337/db07-056317698597) Buteau J (2008) GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival. Diabetes Metab 34(Suppl 2):S73-77. https://doi.org/10.1016/S1262-3636(08)73398-6. (PMID: 10.1016/S1262-3636(08)73398-618640589) Galvin SG, Kay RG, Foreman R et al (2021) The human and mouse islet peptidome: effects of obesity and type 2 diabetes, and assessment of intraislet production of glucagon-like peptide-1. J Proteome Res 20(9):4507–4517. https://doi.org/10.1021/acs.jproteome.1c00463. (PMID: 10.1021/acs.jproteome.1c00463344239918419866) Segerstolpe Å, Palasantza A, Eliasson P et al (2016) Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab 24(4):593–607. https://doi.org/10.1016/j.cmet.2016.08.020. (PMID: 10.1016/j.cmet.2016.08.020276676675069352) Campbell-Thompson M, Wasserfall C, Kaddis J et al (2012) Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 28(7):608–617. https://doi.org/10.1002/dmrr.2316. (PMID: 10.1002/dmrr.2316225856773456997) Chen Y-C, Klimek-Abercrombie AM, Potter KJ et al (2022) Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients. Am J Transplant 22(8):1992–2005. https://doi.org/10.1111/ajt.17076. (PMID: 10.1111/ajt.1707635506189) Bankhead P, Loughrey MB, Fernández JA et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1):16878. https://doi.org/10.1038/s41598-017-17204-5. (PMID: 10.1038/s41598-017-17204-5292038795715110) Schmidt U, Weigert M, Broaddus C, Myers G (2018) Cell Detection with Star-Convex Polygons. In: Frangi AF, Schnabel JA, Davatzikos C, Alberola-López C, Fichtinger G (eds) Medical Image Computing and Computer Assisted Intervention – MICCAI 2018. Springer International Publishing, Cham, pp 265–273. https://doi.org/10.1007/978-3-030-00934-2_30. (PMID: 10.1007/978-3-030-00934-2_30) Apaolaza PS, Petropoulou P-I, Rodriguez-Calvo T (2021) Whole-slide image analysis of human pancreas samples to elucidate the immunopathogenesis of type 1 diabetes using the QuPath software. Front Mol Biosci 8:689799. https://doi.org/10.3389/fmolb.2021.689799. (PMID: 10.3389/fmolb.2021.689799341790948226255) Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A (2021) Cell Profiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22(1):433. https://doi.org/10.1186/s12859-021-04344-9. (PMID: 10.1186/s12859-021-04344-9345075208431850) Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9(1):62–66. https://doi.org/10.1109/TSMC.1979.4310076. (PMID: 10.1109/TSMC.1979.4310076) Marchetti P, Lupi R, Bugliani M et al (2012) A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 55(12):3262–3272. https://doi.org/10.1007/s00125-012-2716-9. (PMID: 10.1007/s00125-012-2716-922965295) Arrojo E, Drigo R, Jacob S, García-Prieto CF et al (2019) Structural basis for delta cell paracrine regulation in pancreatic islets. Nat Commun 10(1):3700. https://doi.org/10.1038/s41467-019-11517-x. (PMID: 10.1038/s41467-019-11517-x) Sims EK, Geyer SM, Long SA, Herold KC (2023) High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment. Diabetologia 66(12):2283–2291. https://doi.org/10.1007/s00125-023-06003-5. (PMID: 10.1007/s00125-023-06003-537667106) Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS (2012) Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA 308(22):2337–2339. https://doi.org/10.1001/jama.2012.15008. (PMID: 10.1001/jama.2012.1500823232891) Wright JJ, Dulaney A, Williams JM et al (2023) Longitudinal MRI Shows progressive decline in pancreas size and altered pancreas shape in type 1 diabetes. J Clin Endocrinol Metab 108(10):2699–2707. https://doi.org/10.1210/clinem/dgad150. (PMID: 10.1210/clinem/dgad1503693858710505530) Lam CJ, Chatterjee A, Shen E, Cox AR, Kushner JA (2019) Low-level insulin content within abundant non-β islet endocrine cells in long-standing type 1 diabetes. Diabetes 68(3):598–608. https://doi.org/10.2337/db18-0305. (PMID: 10.2337/db18-030530552110) Sims EK, Bahnson HT, Nyalwidhe J et al (2018) Proinsulin secretion is a persistent feature of type 1 diabetes. Diabetes Care 42(2):258–264. https://doi.org/10.2337/dc17-2625. (PMID: 10.2337/dc17-2625305308506341288) Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334–1345. https://doi.org/10.2337/db16-1343. (PMID: 10.2337/db16-1343281377935399615) Eizirik DL, Pasquali L, Cnop M (2020) Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol 16(7):349–362. https://doi.org/10.1038/s41574-020-0355-7. (PMID: 10.1038/s41574-020-0355-732398822) Ikegami H, Babaya N, Noso S (2021) β-Cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes. J Diabetes Investig 12(9):1526–1539. https://doi.org/10.1111/jdi.13576. (PMID: 10.1111/jdi.13576339936428409822) Holter MM, Saikia M, Cummings BP (2022) Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion. Front Endocrinol (Lausanne) 13:934775. https://doi.org/10.3389/fendo.2022.934775. (PMID: 10.3389/fendo.2022.93477535957816) Campbell SA, Golec DP, Hubert M et al (2020) Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes. Mol Metab 39:101014. https://doi.org/10.1016/j.molmet.2020.101014. (PMID: 10.1016/j.molmet.2020.101014324135867260680) Ramzy A, Asadi A, Kieffer TJ (2020) Revisiting proinsulin processing: evidence that human β-cells process proinsulin with Prohormone Convertase (PC) 1/3 but not PC2. Diabetes 69(7):1451–1462. https://doi.org/10.2337/db19-0276. (PMID: 10.2337/db19-027632291281) Piran R, Lee S-H, Li C-R, Charbono A, Bradley LM, Levine F (2014) Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes. Cell Death Dis 5:e1357. https://doi.org/10.1038/cddis.2014.311. (PMID: 10.1038/cddis.2014.311250775434123101) Reddy S, Pathipati P, Bai Y, Robinson E, Ross JM (2005) Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study. J Mol Histol 36(4):289–300. https://doi.org/10.1007/s10735-005-7330-4. (PMID: 10.1007/s10735-005-7330-416200462) Jeffery N, Richardson S, Chambers D, Morgan NG, Harries LW (2019) Cellular stressors may alter islet hormone cell proportions by moderation of alternative splicing patterns. Hum Mol Genet 28(16):2763–2774. https://doi.org/10.1093/hmg/ddz094. (PMID: 10.1093/hmg/ddz094310986406687954) Flamez D, Roland I, Berton A et al (2010) A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia 53(7):1372–1383. https://doi.org/10.1007/s00125-010-1714-z. (PMID: 10.1007/s00125-010-1714-z20379810) Md Moin AS, Dhawan S, Shieh C, Butler PC, Cory M, Butler AE (2016) Increased hormone-negative endocrine cells in the pancreas in type 1 diabetes. J Clin Endocrinol Metab 101(9):3487–3496. https://doi.org/10.1210/jc.2016-1350. (PMID: 10.1210/jc.2016-1350273005745010569) |
| Grant Information: | 3-APF-2022-1141-A-N United States JDRF; 5-CDA-2020-949-A-N United States JDRF; AWD-019767 JDFC 2021 United States JDRF; No 115797 Horizon 2020 Framework Programme; No 945268 Horizon 2020 Framework Programme; CIHR PJT-153156 Canada CAPMC CIHR |
| Contributed Indexing: | Keywords: Beta cell dysfunction; Prohormone convertase 1/3; Proinsulin; Quantitative image analysis |
| Substance Nomenclature: | EC 3.4.21.93 (Proprotein Convertase 1) |
| Entry Date(s): | Date Created: 20241015 Date Completed: 20241128 Latest Revision: 20241212 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11604696 |
| DOI: | 10.1007/s00125-024-06275-5 |
| PMID: | 39404844 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1432-0428 |
|---|---|
| DOI: | 10.1007/s00125-024-06275-5 |